Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT06034457
Other study ID # 23-814
Secondary ID
Status Enrolling by invitation
Phase
First received
Last updated
Start date January 18, 2024
Est. completion date June 1, 2025

Study information

Verified date March 2024
Source The Cleveland Clinic
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The study objective is to evaluate the efficacy of the WeightWatchers (WW) GLP-1 behavioral program + WW Clinic (formerly known as Sequence medical weight management program) on weight loss and related outcomes. Participants will be invited to take part and answer surveys at 0, 12 and 24 weeks.


Description:

This is a 24 week prospective single-arm efficacy outcomes study. Up to 180 adult participants who are currently enrolled in WW GLP-1 behavioral program program + WW Clinic (formerly known as Sequence medical weight management program) and already prescribed semaglutide or tirzepatide. The application of a comprehensive lifestyle-based intervention focused on dietary intake, physical activity, support and behavioral principles in conjunction with anti-obesity medication (AOM) is novel and may increase AOM efficacy while minimizing maintenance concerns. As obesity care can now be delivered virtually, it will also include an innovative strategy of virtual/remotely delivered medical care via Sequence and WW. Further, this study will examine multiple psychosocial domains associated with weight loss and weight loss related outcomes including physical activity, dietary behavior, disordered eating, depression symptoms, internalized weight bias and community, that have not been examined in AOM trials.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 180
Est. completion date June 1, 2025
Est. primary completion date December 31, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion criteria: 1. 18 years or older 2. BMI of >30 or BMI of >27 with one or more weight related medically qualifying condition (hypertension, dyslipidemia, sleep apnea, cardiovascular disease) 3. Access to a smartphone or tablet that runs iOS/iPadOS 15.0 or later, or Android 7.0 or later 4. A prescription for Wegovy, Mounjaro, or Zepbound Exclusion criteria: 1. Diabetes 2. Personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia type 2 3. History of pancreatitis within 180 days 4. Previous surgical obesity treatment 5. Use of other anti-obesity medication in last 90 days 6. Use of GLP-1 within the last 180 days 7. Lost weight >11 lbs in the last 90 days 8. Pregnant, breastfeeding, intends to become pregnant, of child-bearing potential and not using a highly effective contraceptive method

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United States Cleveland Clinic Cleveland Ohio

Sponsors (1)

Lead Sponsor Collaborator
The Cleveland Clinic

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Blood pressure changes (systolic and diastolic) in mmHg from week 0 to week 24 Effect of WW + WW Clinic (formerly known as Sequence) on blood pressure changes at 24 weeks 0 to 24 weeks
Other Change in Quality of Life scores from week 0 to week 24 Effect of WW + WW Clinic (formerly known as Sequence) on Quality of Life (QOL) scores 0 to 24 weeks
Other Changes in Well-being scores from week 0 to week 24 Effect of WW + WW Clinic (formerly known as Sequence) on Well-being at 24 weeks 0 to 24 weeks
Other Changes in Physical Activity scores from week 0 to week 24 Effect of WW + WW Clinic (formerly known as Sequence) on Physical Activity at 24 weeks 0 to 24 weeks
Other Changes in Diet Quality scores from week 0 to week 24 Effect of WW + WW Clinic (formerly known as Sequence) on Diet Quality at 24 weeks 0 to 24 weeks
Other Changes in Hunger scores from week 0 to week 24 Effect of WW + WW Clinic (formerly known as Sequence)on Hunger scores at 24 weeks 0 to 24 weeks
Other Changes in Stress scores from week 0 to week 24 Effect of WW + WW Clinic (formerly known as Sequence) on Stress at 24 weeks 0 to 24 weeks
Other Changes in Internalized Weight Bias scores from week 0 to week 24 Effect of WW + WW Clinic (formerly known as Sequence) on Internalized Weight Bias 0 to 24 weeks
Other Changes in Emotional Eating scores from week 0 to week 24 Effect of WW + WW Clinic (formerly known as Sequence) on Emotional Eating scores 0 to 24 weeks
Other Changes in Satisfaction scores from week 0 to week 24 Effect of WW + WW Clinic (formerly known as Sequence) on Satisfaction scores 0 to 24 weeks
Other Changes in Community scores from week 0 to week 24 Effect of WW + WW Clinic (formerly known as Sequence) on Community scores 0 to 24 weeks
Other Changes in Habit Strength scores from week 0 to week 24 Effect of WW + WW Clinic (formerly known as Sequence) on Habit Strength scores 0 to 24 weeks
Other Changes in Food Craving scores from week 0 to week 24 Effect of WW + WW Clinic (formerly known as Sequence) on Food Craving scores 0 to 24 weeks
Other Changes in Self-Compassion scores from week 0 to week 24 Effect of WW + WW Clinic (formerly known as Sequence) on Self-Compassion scores 0 to 24 weeks
Other Changes in Disordered Eating Behaviors scores from week 0 to week 24 Effect of WW + WW Clinic (formerly known as Sequence) on Disordered Eating Behavior scores 0 to 24 weeks
Other Changes in reported GLP1 Side Effects from week 0 to week 24 Effect of WW + WW Clinic (formerly known as Sequence) on Side Effects scores 0 to 24 weeks
Other Changes in Restraint/Disinhibition scores from week 0 to week 24 Effect of WW + WW Clinic (formerly known as Sequence) on Ristraint/Disinhibition scores 0 to 24 weeks
Other Changes in Body Appreciation scores from week 0 to week 24 Effect of WW + WW Clinic (formerly known as Sequence) on Body Appreciation scores 0 to 24 weeks
Other Changes in Depression symptom scores from week 0 to week 24 Effect of WW + WW Clinic (formerly known as Sequence) on Depression symptoms 0 to 24 weeks
Primary Change in weight in pounds from week 0 to week 24 Effect of WW GLP1 behavioral program + WW Clinic (formerly known as Sequence) on weight loss at 24 weeks. 0 to 24 weeks
Secondary Weight loss percentage change from week 0 to week 24 Effect of WW + WW Clinic (formerly known as Sequence) on weight loss at 12 weeks and % reaching 5, 10, 15, 20 % body weight loss at 24 weeks. 0 to 24 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2